Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: The role of dosimetric and clinical factors
about
The impacts of single nucleotide polymorphisms in genes of cell cycle and NF-kB pathways on the efficacy and acute toxicities of radiotherapy in patients with nasopharyngeal carcinomaThe different dose-volume effects of normal tissue complication probability using LASSO for acute small-bowel toxicity during radiotherapy in gynecological patients with or without prior abdominal surgery.Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessmentsUsing multivariate regression model with least absolute shrinkage and selection operator (LASSO) to predict the incidence of Xerostomia after intensity-modulated radiotherapy for head and neck cancer.Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy.Radiobiological evaluation of intensity modulated radiation therapy treatments of patients with head and neck cancer: A dual-institutional study.Assessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complicatiLASSO NTCP predictors for the incidence of xerostomia in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.Impact of Node Negative Target Volume Delineation on Contralateral Parotid Gland Dose Sparing Using IMRT in Head and Neck Cancer.Bulk evaluation and comparison of radiotherapy treatment plans for breast cancer.Optimizing Radiotherapy in HPV-Associated Oropharyngeal Cancer Patients.The QUANTEC criteria for parotid gland dose and their efficacy to prevent moderate to severe patient-rated xerostomia.Assessment of radiation-induced xerostomia: validation of the Italian version of the xerostomia questionnaire in head and neck cancer patients.Parotid gland mean dose as a xerostomia predictor in low-dose domains.XRCC3 polymorphisms are associated with the risk of developing radiation-induced late xerostomia in nasopharyngeal carcinoma patients treated with intensity modulation radiated therapy.Design and Selection of Machine Learning Methods Using Radiomics and Dosiomics for Normal Tissue Complication Probability Modeling of Xerostomia.
P2860
Q33648870-DB6BCB42-B6E6-4C89-8B54-A8A1620A503AQ34014421-9F50E98D-3F07-4404-995C-B0A9DC0B5A6FQ34498711-DEA438C5-E4FA-49E9-BFEC-84A6C552D44BQ35107930-837EE17C-38E4-4F58-8C7F-C7CDBD830F1AQ35973996-B44DAF0D-0B92-4F72-AB51-CC6E061373C8Q36124529-EEBD607B-F717-4C2C-9566-C2B74C79393CQ36235453-ACA3E27D-73D4-477B-9544-9B97F1920FD7Q37743816-C6372DB4-5CB1-4878-A4E3-A231FA8AF819Q38381626-E8BCFC34-71D6-4860-BF31-C9FA9B1813A4Q38850415-6A9D6121-1C45-4A83-B0FA-FD4B460F2BA0Q38971561-AD040E5E-C486-4F82-A056-F4F05B6C443FQ45795379-84C26243-E264-4BAE-91A4-A124686D5504Q48065098-D55CD24E-5E0A-4803-A9E8-03212C5D5CEBQ48147430-51968DF4-4CA3-4375-94FB-56C370720366Q54226684-77EE0CA8-32AC-4422-9BA9-77A143893DB2Q55428458-129DDDC5-ED6E-4621-B734-339B8B82C535
P2860
Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: The role of dosimetric and clinical factors
description
article
@en
im Mai 2011 veröffentlicher wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2012
@uk
name
Development of NTCP models for ...... osimetric and clinical factors
@en
Development of NTCP models for ...... osimetric and clinical factors
@nl
type
label
Development of NTCP models for ...... osimetric and clinical factors
@en
Development of NTCP models for ...... osimetric and clinical factors
@nl
prefLabel
Development of NTCP models for ...... osimetric and clinical factors
@en
Development of NTCP models for ...... osimetric and clinical factors
@nl
P2093
P50
P1476
Development of NTCP models for ...... osimetric and clinical factors
@en
P2093
Arjan Vissink
C René Leemans
Fred R Burlage
Henk P Bijl
Johannes A Langendijk
Miranda E M C Christianen
Olga Chouvalova
Patricia Doornaert
Phil W Koken
P356
10.1016/J.RADONC.2011.05.010
P577
2011-05-31T00:00:00Z